S&P 및 Nasdaq 내재가치 문의하기

Eli Lilly and Company LLY NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
86/100
5/7 Pass
SharesGrow Intrinsic Value
$919.68
-0.3%
Analyst Price Target
$1,243.95
+34.8%

Eli Lilly and Company (LLY) 은(는) 상장 기업입니다 헬스케어 섹터의 제약 산업에서 운영. 본사 소재지는 Indianapolis, IN, 미국. 현재 CEO는 David A. Ricks.

LLY 을(를) 보유 IPO 날짜 1972-06-01, 47,000 명의 정규직 직원, 에 상장 NYSE, 시가총액 $871.6B.

Eli Lilly and Company 소개

Eli Lilly and Company is a global pharmaceutical company that discovers, develops, and markets a comprehensive portfolio of human pharmaceuticals across multiple therapeutic areas. The company's offerings span diabetes management with products like Humalog and Humulin insulins, oncology with agents including Alimta, Cyramza, and Verzenio for various cancers, immunology with Olumiant and Taltz for rheumatoid arthritis and psoriatic conditions, and neuroscience with medications such as Cymbalta and Zyprexa. Additionally, Eli Lilly provides treatments for other indications including erectile dysfunction, osteoporosis, and COVID-19, supported by strategic collaborations with leading biotechnology firms. Founded in 1876 and headquartered in Indianapolis, Indiana, the company maintains a strong commitment to innovation and therapeutic advancement across its diverse drug pipeline.

📍 Lilly Corporate Center, Indianapolis, IN 46285 📞 317 276 2000
회사 세부정보
섹터헬스케어
산업제약
국가미국
거래소NYSE
통화USD
IPO 날짜1972-06-01
CEODavid A. Ricks
직원 수47,000
거래 정보
현재 가격$922.50
시가역액$871.6B
52주 범위623.78-1133.95
베타0.50
ETF아니오
ADR아니오
CUSIP532457108
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기